200 related articles for article (PubMed ID: 21748284)
1. A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120.
Bandaru VV; Patel N; Ewaleifoh O; Haughey NJ
J Neuroimmune Pharmacol; 2011 Dec; 6(4):640-9. PubMed ID: 21748284
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia.
Haughey NJ; Cutler RG; Tamara A; McArthur JC; Vargas DL; Pardo CA; Turchan J; Nath A; Mattson MP
Ann Neurol; 2004 Feb; 55(2):257-67. PubMed ID: 14755730
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal from repeated morphine administration augments expression of the RhoA network in the nucleus accumbens to control synaptic structure.
Cahill ME; Browne CJ; Wang J; Hamilton PJ; Dong Y; Nestler EJ
J Neurochem; 2018 Oct; 147(1):84-98. PubMed ID: 30071134
[TBL] [Abstract][Full Text] [Related]
4. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.
Hu S; Sheng WS; Lokensgard JR; Peterson PK
J Infect Dis; 2005 Mar; 191(6):886-9. PubMed ID: 15717263
[TBL] [Abstract][Full Text] [Related]
5. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.
Henry BL; Geyer MA; Buell MR; Perry W; Young JW; Minassian A;
Behav Pharmacol; 2014 Feb; 25(1):12-22. PubMed ID: 24281153
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.
Thaney VE; Sanchez AB; Fields JA; Minassian A; Young JW; Maung R; Kaul M
J Neurovirol; 2018 Apr; 24(2):156-167. PubMed ID: 29075998
[TBL] [Abstract][Full Text] [Related]
7. The neurotrophin receptor p75 mediates gp120-induced loss of synaptic spines in aging mice.
Bachis A; Wenzel E; Boelk A; Becker J; Mocchetti I
Neurobiol Aging; 2016 Oct; 46():160-8. PubMed ID: 27498053
[TBL] [Abstract][Full Text] [Related]
8. Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.
Fitting S; Stevens DL; Khan FA; Scoggins KL; Enga RM; Beardsley PM; Knapp PE; Dewey WL; Hauser KF
J Pharmacol Exp Ther; 2016 Jan; 356(1):96-105. PubMed ID: 26542403
[TBL] [Abstract][Full Text] [Related]
9. Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.
Hoefer MM; Sanchez AB; Maung R; de Rozieres CM; Catalan IC; Dowling CC; Thaney VE; Piña-Crespo J; Zhang D; Roberts AJ; Kaul M
Exp Neurol; 2015 Jan; 263():221-34. PubMed ID: 25246228
[TBL] [Abstract][Full Text] [Related]
10. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.
Podhaizer EM; Zou S; Fitting S; Samano KL; El-Hage N; Knapp PE; Hauser KF
J Neuroimmune Pharmacol; 2012 Dec; 7(4):877-91. PubMed ID: 22101471
[TBL] [Abstract][Full Text] [Related]
11. Effects of Morphine on Gp120-induced Neuroinflammation Under Immunocompetent Vs. Immunodeficient Conditions.
Canonico D; Casale S; Look T; Cao L
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):24-40. PubMed ID: 35059975
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.
Silverstein PS; Shah A; Weemhoff J; Kumar S; Singh DP; Kumar A
Curr HIV Res; 2012 Jul; 10(5):369-83. PubMed ID: 22591361
[TBL] [Abstract][Full Text] [Related]
13. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
Nye HE; Nestler EJ
Mol Pharmacol; 1996 Apr; 49(4):636-45. PubMed ID: 8609891
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
Henry BL; Geyer MA; Buell M; Perry W; Young JW; Minassian A;
Behav Brain Res; 2013 Jan; 236(1):210-220. PubMed ID: 22960458
[TBL] [Abstract][Full Text] [Related]
15. Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.
Avdoshina V; Biggio F; Palchik G; Campbell LA; Mocchetti I
Glia; 2010 Oct; 58(13):1630-9. PubMed ID: 20578038
[TBL] [Abstract][Full Text] [Related]
16. Decreased glial and synaptic glutamate uptake in the striatum of HIV-1 gp120 transgenic mice.
Melendez RI; Roman C; Capo-Velez CM; Lasalde-Dominicci JA
J Neurovirol; 2016 Jun; 22(3):358-65. PubMed ID: 26567011
[TBL] [Abstract][Full Text] [Related]
17. Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: implications for HIV-associated neurodegeneration.
Banerjee S; Liao L; Russo R; Nakamura T; McKercher SR; Okamoto S; Haun F; Nikzad R; Zaidi R; Holland E; Eroshkin A; Yates JR; Lipton SA
Exp Neurol; 2012 Aug; 236(2):298-306. PubMed ID: 22575597
[TBL] [Abstract][Full Text] [Related]
18. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.
Kesby JP; Markou A; Semenova S;
Eur Neuropsychopharmacol; 2015 Jan; 25(1):141-50. PubMed ID: 25476577
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of atorvastatin against morphine-induced tolerance and dependence in mice.
Pajohanfar NS; Mohebbi E; Rad A; Pejhan A; Nazemi S; Amin B
Brain Res; 2017 Feb; 1657():333-339. PubMed ID: 28062186
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
